DK284389A - Precursorantigener - Google Patents

Precursorantigener Download PDF

Info

Publication number
DK284389A
DK284389A DK284389A DK284389A DK284389A DK 284389 A DK284389 A DK 284389A DK 284389 A DK284389 A DK 284389A DK 284389 A DK284389 A DK 284389A DK 284389 A DK284389 A DK 284389A
Authority
DK
Denmark
Prior art keywords
protein
retrovirus
precursor
hiv
directed towards
Prior art date
Application number
DK284389A
Other languages
English (en)
Other versions
DK284389D0 (da
DK175668B1 (da
Inventor
Luc Montagnier
Ara Hovanessian
Anne Laurent
Bernard Krust
Marie-Anne Rey
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8807817A external-priority patent/FR2632644B1/fr
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of DK284389D0 publication Critical patent/DK284389D0/da
Publication of DK284389A publication Critical patent/DK284389A/da
Application granted granted Critical
Publication of DK175668B1 publication Critical patent/DK175668B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
DK198902843A 1988-06-09 1989-06-09 Precursor for kappeglycolproteiner fra HIV-2-retrovirus og beslægtede antigener DK175668B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20434688A 1988-06-09 1988-06-09
US20434688 1988-06-09
FR8807817 1988-06-10
FR8807817A FR2632644B1 (fr) 1988-06-10 1988-06-10 Antigenes precurseurs des glycoproteines d'enveloppe d'un retrovirus humain hiv-2 et antigenes presentant une parente immunologique avec ces derniers. preparation de ces antigenes. application au diagnostic

Publications (3)

Publication Number Publication Date
DK284389D0 DK284389D0 (da) 1989-06-09
DK284389A true DK284389A (da) 1989-12-10
DK175668B1 DK175668B1 (da) 2005-01-10

Family

ID=26226719

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198902843A DK175668B1 (da) 1988-06-09 1989-06-09 Precursor for kappeglycolproteiner fra HIV-2-retrovirus og beslægtede antigener

Country Status (9)

Country Link
EP (1) EP0354072B1 (da)
JP (1) JP3093763B2 (da)
AT (1) ATE122236T1 (da)
CA (1) CA1341488C (da)
DE (1) DE68922540T2 (da)
DK (1) DK175668B1 (da)
ES (1) ES2074085T3 (da)
HK (1) HK167295A (da)
PT (1) PT90800B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005078443A1 (en) * 2004-02-13 2005-08-25 Inverness Medical Switzerland Gmbh Determination of infection by the immune response to a carbohydrate moiety

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0249611A4 (en) * 1985-11-14 1988-04-26 Harvard College T-LYMPHOTROPHIC VIRUS.
EP0269520A3 (fr) * 1986-11-21 1988-08-24 Institut Pasteur Rétrovirus du type HIV-2 susceptible de provoquer le sida, et ses constituants antigéniques et nucléiques
AU608294B2 (en) * 1987-01-16 1991-03-28 Institut Pasteur Peptides having immunological properties 2-hiv-2

Also Published As

Publication number Publication date
EP0354072B1 (fr) 1995-05-10
HK167295A (en) 1995-11-03
DK284389D0 (da) 1989-06-09
ES2074085T3 (es) 1995-09-01
DE68922540D1 (de) 1995-06-14
JP3093763B2 (ja) 2000-10-03
EP0354072A1 (fr) 1990-02-07
JPH02119791A (ja) 1990-05-07
PT90800A (pt) 1989-12-29
DK175668B1 (da) 2005-01-10
ATE122236T1 (de) 1995-05-15
CA1341488C (fr) 2005-08-30
DE68922540T2 (de) 1995-10-05
PT90800B (pt) 1994-11-30

Similar Documents

Publication Publication Date Title
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
ATE64601T1 (de) Lymphadenopathie-assoziierte huellenantigene und deren verwendungen.
DK513388A (da) Peptider med immunologiske egenskaber svarende til hiv-2 virus, nucleotidsekvenser, der koder for saadanne peptider, antigene og immunogene midler indeholdende saadanne peptider samt fremgangsmaade og kit til in vitro diagnose af hiv-2
MY136081A (en) Modified hiv - 1gag p17 peptide and immunogenic composition
IL89701A0 (en) Recombinant retroviruses,method for the production thereof and pharmaceutical composition containing the same
DE60039036D1 (de) Hiv-peptide, antigene und impfstoffzusammensetzungen
DK0673948T3 (da) Peptider, der stammer fra et retrovirus fra HIV-gruppen, og deres anvendelse
FI885296A0 (fi) Rekombinant hiv-2 polypeptid.
DK284389D0 (da) Precursorantigener
NZ220500A (en) Recombinant felv polypeptide; vaccine and expression vectors
DK0439601T3 (da) Præparat indeholdende en B-epitop fra kappe- glycoproteinet fra et retrovirus og en T-epitop fra et protein, der er forskelligt fra dette retrovirus
WO1990013314A3 (fr) Antigenes de la glycoproteine transmembranaire d'enveloppe d'un retrovirus humain du type hiv-2 (antigenes presentant avec eux une parente immunologique)
OA08716A (fr) Peptides susceptibles d'être reconnus par des anticorps induits contre des retrovirus d'immunodéficience humaine (virus HIV), leurs applications au diagnostic des infections dues à certains de ces virus et, le cas échéant, à la vaccination contre le sida.

Legal Events

Date Code Title Description
PUP Patent expired